Clinicopathological Outcomes and Prognosis of Elderly Patients (≥ 65 Years) with Gastric Gastrointestinal Stromal Tumors (GISTs) Undergoing Curative-Intent Resection: a Multicenter Data Review

[1]  F. van Coevorden,et al.  Elderly patients with gastrointestinal stromal tumour (GIST) receive less treatment irrespective of performance score or comorbidity - A retrospective multicentre study in a large cohort of GIST patients. , 2017, European journal of cancer.

[2]  K. Tao,et al.  Prognostic role of tumor necrosis in patients undergoing curative resection for gastric gastrointestinal stromal tumor: a multicenter analysis of 740 cases in China , 2017, Cancer medicine.

[3]  A. Muratore,et al.  Pulmonary Complications after Surgery for Rectal Cancer in Elderly Patients: Evaluation of Laparoscopic versus Open Approach from a Multicenter Study on 477 Consecutive Cases , 2017, Gastroenterology research and practice.

[4]  T. Yamano,et al.  Influence of age and comorbidity on prognosis and application of adjuvant chemotherapy in elderly Japanese patients with colorectal cancer: A retrospective multicentre study. , 2017, European journal of cancer.

[5]  P. Zhang,et al.  Clinicopathological and Prognostic Analysis of Primary Gastrointestinal Stromal Tumor Presenting with Gastrointestinal Bleeding: a 10-Year Retrospective Study , 2017, Journal of Gastrointestinal Surgery.

[6]  K. Matsuda,et al.  Systematic review of laparoscopic vs open surgery for colorectal cancer in elderly patients. , 2016, World journal of gastrointestinal oncology.

[7]  H. Gan,et al.  Inclusion of elderly patients in oncology clinical trials. , 2016, Annals of oncology : official journal of the European Society for Medical Oncology.

[8]  M. McCarter,et al.  Soft Tissue Sarcoma, Version 2.2018, NCCN Clinical Practice Guidelines in Oncology. , 2016, Journal of the National Comprehensive Cancer Network : JNCCN.

[9]  K. Søreide,et al.  Global epidemiology of gastrointestinal stromal tumours (GIST): A systematic review of population-based cohort studies. , 2016, Cancer epidemiology.

[10]  L. Harlan,et al.  Gastrointestinal stromal tumors: Treatment patterns of a population‐based sample , 2015, Journal of surgical oncology.

[11]  U. Knippschild,et al.  Impact of age and gender on tumor related prognosis in gastrointestinal stromal tumors (GIST) , 2015, BMC Cancer.

[12]  G. Antoniou,et al.  Laparoscopic colorectal surgery confers lower mortality in the elderly: a systematic review and meta-analysis of 66,483 patients , 2015, Surgical Endoscopy.

[13]  J. Sicklick,et al.  Epidemiology of Gastrointestinal Stromal Tumors in the Era of Histology Codes: Results of a Population-Based Study , 2014, Cancer Epidemiology, Biomarkers & Prevention.

[14]  E. Wu,et al.  Treatment Patterns, Prescribing Decision Drivers, and Predictors of Complete Response Following Disease Recurrence in Gastrointestinal Stromal Tumor Patients—a Chart Extract-Based Approach , 2014, Journal of Gastrointestinal Cancer.

[15]  R. Kapoor,et al.  Five‐year follow up of patients with gastrointestinal stromal tumor: Recurrence‐free survival by risk group , 2013, Asia-Pacific journal of clinical oncology.

[16]  Aki Vehtari,et al.  One vs three years of adjuvant imatinib for operable gastrointestinal stromal tumor: a randomized trial. , 2012, JAMA.

[17]  P. Went,et al.  Frequency, phenotype, and genotype of minute gastrointestinal stromal tumors in the stomach: an autopsy study. , 2011, Human pathology.

[18]  Masayuki Yoshida,et al.  Tumour necrosis is a postoperative prognostic marker for pancreatic cancer patients with a high interobserver reproducibility in histological evaluation , 2010, British Journal of Cancer.

[19]  D. Park,et al.  Current Trends in the Epidemiological and Pathological Characteristics of Gastrointestinal Stromal Tumors in Korea, 2003-2004 , 2010, Journal of Korean medical science.

[20]  C. Antonescu,et al.  Adjuvant imatinib mesylate after resection of localised, primary gastrointestinal stromal tumour: a randomised, double-blind, placebo-controlled trial , 2009, The Lancet.

[21]  M. Federico,et al.  Incidence and clinicopathologic features of gastrointestinal stromal tumors. A population-based study , 2007, BMC Cancer.

[22]  J. Cheville,et al.  Histologic coagulative tumor necrosis as a prognostic indicator of renal cell carcinoma aggressiveness , 2005, Cancer.

[23]  L. Rikkers,et al.  The society for surgery of the alimentary tract postgraduate course , 1991 .

[24]  M. McCarter,et al.  Soft Tissue Sarcoma, Version 2.2016, NCCN Clinical Practice Guidelines in Oncology. , 2016, Journal of the National Comprehensive Cancer Network : JNCCN.

[25]  A. Lacy,et al.  Giant Gastric Gastrointestinal Stromal Tumor (GIST) , 2016, Journal of Gastrointestinal Surgery.